• 🌎 Worldwide
    • 🇺🇸 U.S.
    • 🇨🇦 Canada
    • 🇬🇧 United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home PRO

PRO: Chardan Capital Analyst Sees Over 490% Upside for Shares of 22nd Century

Steven Lachard by Steven Lachard
March 19, 2019
in Analyst Action, Investments, Marijuana Stocks, PRO, Trading, United States
FDA Scientific Advisory Committee Discusses 22nd Century Group’s Reduced Nicotine Cigarettes

Photo Credit - Alexas_Fotos via Pixabay

134
SHARES
ShareShare

In a recently released analyst research report, Chardan Capital Markets, LLC‘s  Senior Research Analyst of Industrial and Consumer Technology, James McIlree, CFA, just reiterated his buy rating on shares of 22nd Century Group Inc. (NYSE:XXII) with a sky-high twelve-month price target.

James McIlree’s new price target of $11.50 USD per share implies a potential upside of approximately 492.78% based on the last traded price of $1.94 USD on the NYSE. The price target of $11.50 “is based on the company garnering royalty revenue for its technology on 10% of the US market share in the next five years, discounted at a 20% annual rate.

While the analyst’s update was largely based on bullish catalysts for 22nd Century Group’s low nicotine tobacco division, many of its shareholders bought in as a result of its hemp division. Therefore, his update was worth mentioning as McIlree’s coverage of the company has been known to move shares of XXII.

According to McIlree’s update, “22nd Century shares rose Thursday in response to testimony from Health and Human Services Secretary Alex Azar to the Senate Finance Committee that indicated support for departing FDA Commissioner Scott Gottlieb’s nicotine and tobacco agenda.”

The research report continued, stating that, “There is tremendous institutional momentum in the FDA’s decade’s long due to the Government shutdown and now Gottlieb’s resignation, we expect the process to move forward this year.”

Be sure to subscribe to updates here so you never miss an important development.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: 22nd Century Group Inc.Chardan Capital Markets LLCJames McIlree CFANYSE:XXIIU.S. Food and Drug Administration

Get Real-Time Updates from MJobserver.com

Unsubscribe
Steven Lachard

Steven Lachard

Steven Lachard is a staff writer for MJobserver.com with a particular focus on marijuana stocks. Beyond MJobserver.com, Steven's pot stock insights have been featured on TalkMarkets.com and more.

Related Posts

Marinol Dronabinol THC Pharmaceutical
Events

30+ Expert Speakers to Present at the 3rd Annual Cannabinoid-Derived Pharmaceuticals Summit

July 9, 2020
FDA Cannabis and CBD News
Press Releases

Charlotte’s Web Steps Up to Support Research to Address FDA’s Request for More Scientific Data

June 9, 2020
Marijuana Stock Earnings Announcement News
Investments

22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020

April 28, 2020
Submitting a Comment to the FDA on CBD in Foods and Beverages
Health

Tetra Receives its 4th FDA Orphan Drug Designation

April 16, 2020
THC BioMed Releases Second Quarter Profitable Results
Investments

22nd Century Group, Inc. Files 2019 Annual Report

March 12, 2020
Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use
Investments

Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use

March 4, 2020
Load More
Next Post
5 Best Performing Canadian Licensed Producer Stocks Today

5 of Today’s Best Performing Canadian L.P. Stocks - March 19, 2019

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🚨 Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

✉️ Subscribe to Our Newsletter!

* indicates required

🔎 Search Marijuana Stocks

📰 Recent News

  • Aleafia Health Launches Everyday Cannabis Brand Divvy
  • Green Thumb Industries Expands Independent Governance with Appointment of Swati Mylavarapu to Board of Directors
  • Healixa Inc. Appoints Kealy Altman as Vice President of Marketing
  • MediPharm Labs Achieves Export Milestone, Ships Cannabis Oil from Australia to Germany
  • Verano Holdings Shares Approved to Trade on OTC Markets Under the Symbol VRNOF
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • 🇺🇸 United States
  • 🇨🇦 Canada
  • 🇬🇧 United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • 📅 Calendar
  • 📊 Databases
  • 📇 Directories
  • 🔔 RSS Feeds
  • 📺 Videos

Find Cannabis Business Services

  • ⚖️ Attorneys & Law Firms
  • 📊 Accountants & Accounting Firms
  • 💡 Consultants & Consulting Firms
  • 📲 Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • 👀 Advertise
  • 📣 DMO Newswire
  • 📇 List in Our Databases

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.